Westblom T U, Marienfeld R D
South Med J. 1985 Oct;78(10):1164-7. doi: 10.1097/00007611-198510000-00005.
Current anticoagulation practices of physicians in an academic medical center were examined by retrospective review of records of 26 patients admitted for uncomplicated deep venous thrombosis (DVT) between 1978 and 1982. Patients received intravenous heparin for an average of 11.5 +/- 2.8 days. Warfarin therapy was started on day 8.3 +/- 3.1 and therapeutic oral anticoagulation was achieved by day 14.5 +/- 4.5. Total hospital stay averaged 16.8 +/- 5.1 days. No patient received concurrent initiation of heparin and warfarin therapy and only two patients received warfarin before day 5. These findings are in contrast to anticoagulation practices in Great Britain and Scandinavia where concurrent initiation of heparin and warfarin has been common practice for many years. Such a regimen is safe and usually requires fewer days of hospitalization for DVT. We conclude that failure to start warfarin therapy on the first hospital day resulted in a costly and unnecessarily prolonged hospital stay.
通过回顾性查阅1978年至1982年间收治的26例单纯性深静脉血栓形成(DVT)患者的病历,研究了某学术医疗中心医生当前的抗凝治疗方法。患者平均接受静脉注射肝素11.5±2.8天。华法林治疗于第8.3±3.1天开始,至第14.5±4.5天达到治疗性口服抗凝。平均住院总天数为16.8±5.1天。没有患者同时开始肝素和华法林治疗,只有两名患者在第5天之前接受了华法林治疗。这些发现与英国和斯堪的纳维亚半岛的抗凝治疗方法形成对比,在那里,同时开始肝素和华法林治疗多年来一直是常见做法。这样的治疗方案是安全的,通常DVT患者住院天数较少。我们得出结论,在入院第一天未开始华法林治疗导致了高昂且不必要的住院时间延长。